Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bulk

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|March 22, 2007
The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiencyS Bulk, J Berkhof, L Rozendaal, et al.
Journal of Clinical Pathology|September 1, 2006
Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rateN W J Bulkmans, S Bulk, M S Ottevanger, et al.
Blood|September 22, 2001
A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levelsG J Brouwers, H L Vos, F W Leebeek, et al.
British Journal of Cancer|January 19, 2012
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implicationsD C Rijkaart, J Berkhof, F J van Kemenade, et al.
Journal of Medical Genetics|November 21, 2013
Mutations in the T (brachyury) gene cause a novel syndrome consisting of sacral agenesis, abnormal ossification of the vertebral bodies and a persistent notochordal canalA V Postma, M Alders, M Sylva, et al.
Lancet (London, England)|October 9, 2007
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialN W J Bulkmans, J Berkhof, L Rozendaal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|March 22, 2007
The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiencyS Bulk, J Berkhof, L Rozendaal, et al.
Journal of Clinical Pathology|September 1, 2006
Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rateN W J Bulkmans, S Bulk, M S Ottevanger, et al.
Blood|September 22, 2001
A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levelsG J Brouwers, H L Vos, F W Leebeek, et al.
British Journal of Cancer|January 19, 2012
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implicationsD C Rijkaart, J Berkhof, F J van Kemenade, et al.
Journal of Medical Genetics|November 21, 2013
Mutations in the T (brachyury) gene cause a novel syndrome consisting of sacral agenesis, abnormal ossification of the vertebral bodies and a persistent notochordal canalA V Postma, M Alders, M Sylva, et al.
Lancet (London, England)|October 9, 2007
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialN W J Bulkmans, J Berkhof, L Rozendaal, et al.
Pageof 2